Reddit Posts
PDSB: Steady Progress in Cancer Immunotherapy
$PDSB biotech update today. Risky, but the risk/reward looks interesting
$PDSB biotech update today. Risky, but the risk/reward looks interesting
High Risk, High Reward? $PDSBβs Phase 3 HPV Cancer Bet
Thoughts on $PDSB? Phase 3 Trial + Strong Phase 2 Data
PDSB - looks like itβs setting up for a serious short squeeze.
PDSB is $1.56 and it might be the last time you ever see it this low. This is your moonshot.
PDSB is $1.56 and it might be the last time you ever see it this low. This is your moonshot.
$PDSB is $1.56 and it might be the last time you ever see it this low. This is your moonshot.
DD: PDS Biotechnology (PDSB) β Undervalued Immunotherapy Pioneer on the Verge of a Major Pivot
Get new runners in our app! 06/5 #postmarket $GTLB $FRZA $PDSB $SDA $TCRX
Perfect Swing Play Setup -- Avalon GloboCare ( NASDAQ: $AVCO ) has an (mRNA)-based technology platform and we could see an IND application any day now
Is PDSB going to do something?
Long Term Investments - Discussion
This is an update from my lady post about $PDSB
$PDSB, PDS Biotech Advances the Fight Against Cancer with its Versamune Platform
$PDSB Low floater shares are scarce 40%+ locked up by institutions & insiders. 22 million shares outstanding.
Turns out it has been $PDSB ceo Frank Bedu Addo the whole time. Buy $PDSBπππ
Turns out it has been $PDSB ceo Frank Bedu Addo the whole time. Buy $PDSBπππ
This is all the DD you need to know about $PDSB. CEO Frank Bedu Addo will defeat Thanos.
Only Frank Bedu Addo can defeat Thanos. Buy $PDSB.
Mentions
Are you thinkin too early for SLS, CING or PDSB or all of em. Seems CING has been gaining traction and SLS also but a bit more slowly
I suggest. Take another 2k Buy SLS call Options for JAN 28 Wait. Sell after BO and buy for the money PDSB shares. Consider this as the last trades in your life.
https://www.stocktitan.net/news/PDSB/pds-biotech-announces-new-u-s-patent-covering-technology-underlying-mqwu5m95x91k.html
PDSB! Keep your eyes on it!!
PDSB you wonβt want to sleep on this
PDSB making silent moves.
Plays for the next few weeks: PDSB, MYO, STIM
I am too. They had a decent earning report. I'm down 20+ but still holding on for the mid term. Same thing with PDSB. About 3k shares in each
PDSB is up pretty good today!
PDSB and MYO did good pre market. Are these plays for today? Is anyone else on these?
MYO and PDSB earnings this week
PDSB and MYO have earnings next week
PDSB announced they will share new data on PDS0101 and PDS01ADC at SITC Nov 7β8, with Phase 3 in progress and FDA meeting for accelerated approval. This is coming 1 day after announcing they have requested to expedite FDA approval. They're going in the right direction. Hope the results are good
PDSB hope we can see similar volume today. If not more. Resistance at 1.16 can easily shoot to $2 for a momentum play. If Phase 3 is a success with FDA approval, we should easily be above $15 IMO. Low market cap for this biotech stock. Notes: PDS0101 vaccine shows 3x longer survival in head and neck cancer and now seeks expedited FDA approval. Their products work and have been tested.
PDSB. Shorts trying their best to keep this one down. 3.51 days to cover π
PDSB don't miss out. No dilution. $10 target once FDA approval hits. PDS0101 shows strong survival results in HPV16-positive head and neck cancer. In Phase 2, patients lived a median of 39.3 months with PDS0101 plus pembrolizumab, compared to about 10β12 months with standard care. The data suggests it works better than existing treatments and has mild side effects.
PDSB brea through $1.15! 1.30 next Don't miss the boat, we're very early. Shorts days to cover is 3.51. hugeeeeee short squeeze potential here.
Break that $1.13 wall PDSB ππ
PDSB is rising! Called that one out earlier! Hope some of you got in
PDSB - got some really good news. FDA approval.ay be dropping very soon. Also heavily shorted, easily see a short squeeze back to $2 here
PDSB thinks they solved cancer. Puts?
PDSB FDA approval . Check it out
Oh yea if PDSB falls. Look for 0.81 and below that 0.50
PDSB def going on my watch list. Potential to hit 0.9708. Needs to break that if it does. Look for 1.09 also a nice double bottom and at major support but still in selling channel. Needs confirmation. MYO you want this support to hold, if it doesn't. Look for 0.87. Bottom at 0.8043 Needs a break to 1.10 for any further upside 1.15,1.20, and 1.310 is your upside
Still in $RDZN, $PDSB (looking for double bottom), $MYO
$PDSB, $MYO, $RDZN, $REI. Longer-term plays
I grabbed some RZLV and CGTX today. Took a shot with 100 shares on each. Already have some PDSB and CABA.
My plays for today and overnight were/are (drum roll please)β¦β¦β¦. PDSBβ¦.. CNTBβ¦β¦ QNCXβ¦..OVID and IGC. Also have a request for 75 shares of bullish (new IPO). Keep fingers crossed my friends /
SGMO up 15% and climbing PDSB up 11% and climbing Somebody knows something. I don't! All I know is I've been holding long and don't know shit! But making money - I belong here (?)
Anyone with inputs on PDSB? Several P2 and P3 trails underway, including with partners such as Merck, Mayo Clinic, National Cancer Institute Market cap is $52M, low volume, trading around 1.15. Analysts range from 4.50 - 13. Insiders purchasing. What's holding this back?
Much prefer RXRX, PDSB, VOR, GUTS
Why can't we pump some dumbass like PDSB, 45.7M shares outstanding around 1.15 - hell, maybe they'll find a cancer cure too ......something along those lines? There's so many out there with millions of shares and around a buck
$PDSB kinda interesting - up trending, CEO with track record of good M&A with bigger pharma, products doing well in late stage clinicals for colon cancer and other cancers. Relatively cheap at \~$1.39, I'm long with 35k shares. Not a core of my port but a fun 'maybe moon' - but yes, I'm here so I'm regarded like everyone else
Anyone on PDSB? Catalyst coming up, bought in at $1.74 for a few shares.
Despite the hype, gemini agrees that PDSB is bullish though. > In summary, while the language is optimistic and promotional, the underlying points about PDSB's potential are well-supported by recent developments and analyst sentiment. It's a high-conviction play for those willing to take on biotech-specific risks, with the potential for substantial returns if the key clinical milestones are met. It's a "moonshot" because of the inherent risk, but one that appears to have strong scientific and clinical backing for its primary asset.
Yeah you donβt hold any PDSB
Opened an IXHL position and sold my PDSB after they announced an offering yesterday afterhours. So much for wanting to go long here. Also back in RVSN, itβs about time they updated us on how things are going.
Continuing to hold PDSB as ASCO draws closer, their data is better than others in the same area (e.g. MRUS trading at $60).
I have practically no idea what I'm doing but, I have my bets on KULR, PDSB, INBS and SOFI (yeah, I know, not technically a "penny stock" anymore but I could see them 10x in the next 5-/+ years or less. Just my opinion, which I've already stated is basically worthless
Anyone see potential for PDSB popping like it did AH yesterday?
The asco abstracts for PDSB are releasing at 5pm ET today, reckon there should be some positive movement prior to that.
ehhh it's always been like that, need to filter through the bots and pnd stocks to find picks. When the chat was around people were able to discuss tickers in real time though. been trying to tell people about PDSB (20% up since first mentioned but can probably run another 60%) and TNYA (grossly oversold imo) - these are biotechs/pharma so just be careful and only invest if you genuinely believe in the company, that is unless you're looking for a quick buck I suppose.
First I mentioned PDSB was towards the end of last month when it was trading around $1.25. It's hit $1.51 premarket today after a nice steady climb the past two weeks, should accelerate after Thursday's catalyst and sustain into early June once we get ASCO abstracts + posters.
10% up on TNYA today and around 4% on PDSB, not too bad
$PDSB has been creeping up the past month. I do think we'll see more significant leaps in the following two/three weeks given they're presenting multiple abstracts at ASCO. Just a disclaimer that I have a position in the stock.
Pleasantly surprised how little the overall market today has affected my biotech picks. TNYA dipped 6% but is steadily climbing back up, meanwhile PDSB is up 8% since open.
welp today was a boring day. had an exam which went fine, in the end I made like Β£300 off WW. god forbid my other PDSB order goes through
had a look at REKR again since I liked the company and bought shares at 1.2 and sold at 2 between December and Jan. Thanks for mentioning it again, will likely jump in on Monday given my PDSB orders arenβt filling.
Sold my OMEX for a nice healthy 1.44, having bought in at 0.64. Think the hype will settle down a bit over the weekend, especially given the 1:8 RS vote being announced (although imo they shouldn't need to, probably a safety net for if the stock dumps) - might buy back in on Monday if the price is right. Sitting on 20k TNYA shares and 13k PDSB (with an order for another 10k). TNYA I was burnt a bit following the drop after positive results during the December call, but at this price I'm more than happy to buy in given their solid pipeline. PDSB is a bit of a gamble but they've got a laundry list of important dates coming up (https://stocktwits.com/dvice2/message/612522015), especially their 3 abstract presentations at ASCO. With some volume I do think this could make big moves.
Happy to see OMEX getting back to where it should be (3-5 minimum), have been mentioning this since Jan. Continuing to hold. Closed my RVSN position at -25% yesterday following the dilution news, will keep an eye on it though if it hits low-mid 0.3. Tried to catch CDIO on the way up but ended up buying at the top π€¦πΎ seeing if this goes anywhere. On the topic of biotech/pharm, Iβm planning on picking up some more TNYA and opening a position in PDSB (20k and ~13k shares respectively).
Thanks for the DD. I'm sitting on some PDSB long calls right now, considering grabbing a bunch of shares while i still can
PDSB just [showed a 42.4-month survival rate compared to the typical 7-12 months](https://finance.yahoo.com/news/pds-biotech-announces-positive-clinical-130000215.html) in their latest trial, and with their [Phase 3 trial starting next month](https://beyondspx.com/article/pds-biotechnology-corporation-pdsb-navigating-the-evolving-immunotherapy-landscape-with-innovative-investigational-therapies) this thing gonna print tendies. They just raised $22M to keep the momentum going - smart money knows what's up.
Yes, new news did come outβPDSB announced a $22M direct offering, which can sometimes put short-term pressure on the stock due to dilution concerns. But that doesn't change the fact that their Phase 2 data is **some of the strongest weβve seen in cancer trials**
PDSB just dropped some [insane Phase 2 trial results showing 42.4-month survival vs the typical 7-12 months](https://finance.yahoo.com/news/pds-biotech-announces-positive-clinical-130000215.html). Their cancer treatment actually works. Not just works - absolutely destroys the competition. [Their pipeline includes both cancer and infectious disease treatments](https://beyondspx.com/article/pds-biotechnology-corporation-pdsb-navigating-the-evolving-immunotherapy-landscape-with-innovative-investigational-therapies), so they're not a one-trick pony. Phase 3 starts in March and they just secured $22M in funding to keep the momentum going. Numbers don't lie - 100% survival rate for patients who got all doses. This is the kind of biotech play that makes millionaires.
PDSB actually crushing it with these trial results. [100% clearance rate vs 50% with standard treatment](https://finance.yahoo.com/news/pds-biotech-announces-circulating-tumor-130000736.html) is no joke for cancer treatment. Their HPV cancer drug Versamune looking like it could be huge - [42.4 month survival rate compared to historical 7-12 months](https://finance.yahoo.com/news/pds-biotech-announces-positive-clinical-130000215.html). Market sleeping on this one while they prep for Phase 3. Biotech plays are always risky but these numbers got me wanting to load up before Phase 3 results drop.
MLGO actually has legit quantum computing tech - they [achieved 99% qubit efficiency](https://finance.yahoo.com/news/microalgo-inc-develops-hybrid-classical-140000733.html) in their new hybrid algorithm. Their [revenue hit $81.89M last year](https://beyondspx.com/article/microalgo-inc-mlgo-revolutionizing-data-processing-with-proprietary-algorithms) with solid margins in their algorithm services. PDSB looking juicy too - their cancer drug [cleared HPV16 cancer cells in 100% of patients](https://finance.yahoo.com/news/pds-biotech-announces-circulating-tumor-130000736.html) vs only 50% with standard treatment. Both plays got actual tech behind them unlike the usual penny stock garbage. MLGO quantum computing play gonna print when AI hype picks back up. PDSB cancer treatment results speak for themselves - phase 3 starting Q1 gonna be lit.
MLGO's [99% qubit efficiency](https://finance.yahoo.com/news/microalgo-inc-develops-hybrid-classical-140000733.html) in their new quantum algo actually means something - these guys aren't just another BS quantum computing pump. Their [92% revenue from algorithm services](https://beyondspx.com/article/microalgo-inc-mlgo-revolutionizing-data-processing-with-proprietary-algorithms) shows they make real money from their tech, not just empty promises. PDSB looking juicy too with that [100% survival rate](https://finance.yahoo.com/news/pds-biotech-announces-circulating-tumor-130000736.html) in their HPV trial - cancer plays always print when the data hits. Both of these are actual companies with actual tech, not your typical WSB lottery tickets.
QS, 2.49bn, NVTS 351.8M, Bksy 269.32m, OUST 433m, and then some biotech that are just moonshots, Apvo and PDSB. So 6 in total.. I also got GSAT, but they are not really smallcap with 3.58bn. All positions are small, and it's just so that I don't forget that they exist, lol.
For context, 15% of my portfolio is also in a biotech stock that is running out of money and tanked 30% this morning⦠$PDSB
They seem to doing the right things - Check out PDSB - I am not in it but many folks I know are
PDSB, fuk u 
$PDSB might be a good entry point I'm currently up 25% and holding.
PDSB could be a 19 bagger if the clinical trial goes well 
PDSB this week, set to rip
$PDSB and $INZY potentially next ones π»π°πΎ
Any recommendations on PDSB
Get new runners in our app! 06/5 #postmarket $GTLB $FRZA $PDSB $SDA $TCRX
Get new runners in our app! 06/5 #postmarket $GTLB $FRZA $PDSB $SDA $TCRX
Get new runners in our app! 06/5 #postmarket $GTLB $FRZA $PDSB $SDA $TCRX
PDSB released good data yesterday, stock will triple todayπππ
All in on PDSB. Just buy and hold. Youβll 10x in two years
Iβm addicted to biotech and got kicked in the balls the past two years. But I also truly believe in the stuff I hold so I wired in more money and bought when the blood letting was happening. Started accumulating PDSB in the $3s. Itβs been on fire with data and now am holding a $100k+ gain in a few short months. (I think it still has potential to go 10x more from here - I think Iβll clear over $1m when itβs bought out) I get that options are fun but it can decimate you If I do options now itβs only on 12 month or longer duration.
Get out of PDSB while youre up bro. Biotech stocks is gambling
Yes buy PDSB stock.
Get it back with PDSB stock
PDSB is the next gamestop